195 related articles for article (PubMed ID: 23782298)
1. Hard palate hyperpigmentation secondary to chronic chloroquine therapy: report of five cases.
de Andrade BA; Fonseca FP; Pires FR; Mesquita AT; Falci SG; Dos Santos Silva AR; Vargas PA; Jorge J; de Almeida OP
J Cutan Pathol; 2013 Sep; 40(9):833-8. PubMed ID: 23782298
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine-induced hyperpigmentation of the hard palate.
Brasil Cda M; Ribeiro CM; Fonseca DD; Gueiros LA; Leao JC
Gen Dent; 2012; 60(2):e74-8. PubMed ID: 22414521
[TBL] [Abstract][Full Text] [Related]
3. Hyperpigmentation of hard palate induced by chloroquine therapy.
de Andrade BA; Padron-Alvarado NA; Muñoz-Campos EM; Morais TL; Martinez-Pedraza R
J Clin Exp Dent; 2017 Dec; 9(12):e1487-e1491. PubMed ID: 29410767
[TBL] [Abstract][Full Text] [Related]
4. Palate hyperpigmentation caused by prolonged use of the anti-malarial chloroquine.
de Melo Filho MR; da Silva CA; da Rocha Dourado M; de Oliveira Pires MB; Pêgo SP; de Freitas EM
Head Neck Pathol; 2012 Mar; 6(1):48-50. PubMed ID: 21877232
[TBL] [Abstract][Full Text] [Related]
5. Hard palate hyperpigmentation-a rare side effect of antimalarials.
Manger K; von Streitberg U; Seitz G; Kleyer A; Manger B
Arthritis Rheumatol; 2018 Jan; 70(1):152. PubMed ID: 28941224
[No Abstract] [Full Text] [Related]
6. Pigmented lichenoid drug eruption secondary to chloroquine therapy: an unusual presentation in lower lip.
Moraes PC; Noce CW; Thomaz LA; Cintra ML; Correa ME
Minerva Stomatol; 2011 Jun; 60(6):327-32. PubMed ID: 21666569
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine-induced hyperpigmentation: a case report.
Melikoglu MA; Melikoglu M; Gurbuz U; Budak BS; Kacar C
J Clin Pharm Ther; 2008 Dec; 33(6):699-701. PubMed ID: 19138249
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced pigmentation of hard palate and skin due to chronic chloroquine therapy: report of two cases.
Gallo CB; Luiz AC; Ferrazzo KL; Migliari DA; Sugaya NN
Clin Exp Dermatol; 2009 Oct; 34(7):e266-7. PubMed ID: 19438573
[No Abstract] [Full Text] [Related]
9. Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus.
Chacón-Dulcey V; López-Labady J; Villarroel-Dorrego M; Frías J; Tirado W; González N; Pérez Alfonzo R
Lupus; 2020 Jun; 29(7):761-766. PubMed ID: 32362181
[TBL] [Abstract][Full Text] [Related]
10. Extensive hard palate hyperpigmentation associated with chloroquine use.
Godinho GV; Paz ALLM; de Araújo Gomes EPA; Garcia CL; Volpato LER
Br J Clin Pharmacol; 2020 Nov; 86(11):2325-2327. PubMed ID: 32307721
[TBL] [Abstract][Full Text] [Related]
11. Medication-induced hyperpigmentation of the oral mucosa.
Noonan V; Kabani S
J Mass Dent Soc; 2010; 58(4):40. PubMed ID: 20225802
[No Abstract] [Full Text] [Related]
12. [Pharmaceutical care for international voyagers: prophylaxis including chloroquine plus proguanil].
Hernández Tintorer JL; Lorduy Osés L
Farm Hosp; 2004; 28(2):137-40. PubMed ID: 15101806
[TBL] [Abstract][Full Text] [Related]
13. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
Leecharoen S; Wangkaew S; Louthrenoo W
J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau.
Ursing J; Kofoed PE; Rodrigues A; Bergqvist Y; Rombo L
Antimicrob Agents Chemother; 2009 Jan; 53(1):180-5. PubMed ID: 18955514
[TBL] [Abstract][Full Text] [Related]
15. A severe adverse reaction to mefloquine and chloroquine prophylaxis.
Lysack JT; Lysack CL; Kvern BL
Aust Fam Physician; 1998 Dec; 27(12):1119-20. PubMed ID: 9919736
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyopathy related to antimalarial therapy with illustrative case report.
Costedoat-Chalumeau N; Hulot JS; Amoura Z; Delcourt A; Maisonobe T; Dorent R; Bonnet N; Sablé R; Lechat P; Wechsler B; Piette JC
Cardiology; 2007; 107(2):73-80. PubMed ID: 16804295
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine-induced myopathy.
Posada C; García-Cruz A; García-Doval I; Millán BS; Teijeira S
Lupus; 2011 Jun; 20(7):773-4. PubMed ID: 21300683
[No Abstract] [Full Text] [Related]
18. [Imatinib-induced pigmentation of the hard palate].
Kluger N; Cassier P; Ruffion N
Ann Dermatol Venereol; 2018 Nov; 145(11):723-724. PubMed ID: 30472997
[No Abstract] [Full Text] [Related]
19. [Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus].
von Schmiedeberg S; Rönnau AC; Schuppe HC; Specker C; Ruzicka T; Lehmann P
Hautarzt; 2000 Feb; 51(2):82-5. PubMed ID: 10743578
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
[No Abstract] [Full Text] [Related]
[Next] [New Search]
